Eli Lilly and Co (NYSE:LLY)

360.99
Delayed Data
As of Dec 09
 0.00 / 0.00%
Today’s Change
231.87
Today|||52-Week Range
375.25
+30.69%
Year-to-Date
Is Invesco Dynamic Pharmaceuticals ETF (PJP) a Strong ETF Right Now?
Dec 09 / Zacks.com - Paid Partner Content
2 Healthcare Stocks That Could Help Your Portfolio
Dec 02 / MotleyFool.com - Paid Partner Content
Zacks Market Edge Highlights: LLY, PFE, JPM, ULTA, QQQ
Dec 09 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: PFE & AZN Ink New M&A Deals, LLY Meets Alzheimer's Study Goal
Dec 02 / Zacks.com - Paid Partner Content
Will There be a Recession in 2023?
Dec 08 / Zacks.com - Paid Partner Content
Why Is Lilly (LLY) Up 4.5% Since Last Earnings Report?
Dec 01 / Zacks.com - Paid Partner Content
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
Dec 08 / MotleyFool.com - Paid Partner Content
Lilly's (LLY) Donanemab Betters Biogen's Alzheimer's Drug
Dec 01 / Zacks.com - Paid Partner Content
2 Top Index Funds Growth Stock Investors Can Buy With Confidence Before 2023
Dec 08 / MotleyFool.com - Paid Partner Content
Are Tech Layoffs Going to Be a Headache for Alexandria Real Estate Equities?
Nov 30 / MotleyFool.com - Paid Partner Content
Relative Strength Found Within These 3 Medical Stocks
Dec 05 / Zacks.com - Paid Partner Content
Biogen's (BIIB) Lecanemab Shows Benefit but With Side Effects
Nov 30 / Zacks.com - Paid Partner Content
Anavex's (AVXL) Lead Alzheimer's Drug Meets Study Goal
Dec 05 / Zacks.com - Paid Partner Content
Biogen (BIIB) Down on Report of Death in Alzheimer's Study
Nov 29 / Zacks.com - Paid Partner Content
2 Giant Stocks to Consider Buying Right Now and 1 to Avoid
Dec 05 / StockNews.com - Paid Partner Content
Up 32% in 2022, Is Eli Lilly Stock Still a Buy?
Nov 27 / MotleyFool.com - Paid Partner Content
2 Unstoppable Stocks That Could Make You Richer in 2023 and Beyond
Dec 02 / MotleyFool.com - Paid Partner Content